This is due to alteration in toll-like receptor 4 (TLR4) signalling pathways, which lead to a switch of tumour-associated macrophages toward the protumoural M2-like phenotype, as well as to a reduction of T cell-mediated immunity [52]. This evidence concerns the gene TLR4 and neoplasm.